BRUKER CORPORATION (NASDAQ:BRKR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

0

BRUKER CORPORATION (NASDAQ:BRKR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 23, 2017, Bruker Corporation (the “Company”) was notified by Michael G. Knell, Vice President of Finance and Chief Accounting Officer, of his decision to resign from the Company to pursue other opportunities, effective March 31, 2017. Mr. Knell also resigned from all other positions he held with the Company and its affiliates. There were no disagreements with Mr. Knell on any matter of accounting principles or practices or financial statement disclosure. Mr. Knell has agreed to continue his employment and provide transition assistance until April 21, 2017.

Effective March 23, 2017, Anthony L. Mattacchione, the Company’s Chief Financial Officer and Senior Vice President, who currently serves as the Company’s principal financial officer, assumed Mr. Knell’s responsibilities as the Company’s principal accounting officer.

Mr. Knell is entitled to receive a cash incentive award payment for 2016 performance in the amount of $68,788. Additionally, Mr. Knell is eligible to receive a payment of $116,573 in connection with his departure, as well as COBRA healthcare coverage for a period of up to six months and certain other benefits, subject to satisfactory completion of certain transition responsibilities. Mr. Knell will be bound by non-competition and non-solicitation obligations to the Company for a period of one year from the date of his separation from employment.


About BRUKER CORPORATION (NASDAQ:BRKR)

Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive (CBRNE) detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices.

BRUKER CORPORATION (NASDAQ:BRKR) Recent Trading Information

BRUKER CORPORATION (NASDAQ:BRKR) closed its last trading session up +0.19 at 22.82 with 472,650 shares trading hands.